1 / 1

Improved Tissue Survival with Nitric Oxide Donor Injection in Flap Surgery

The study shows enhanced tissue survival with diethylenetriamine NONOate (DETA-NO) treatment in flap surgery, as seen in the comparison of control flap vs. DETA-NO treated flap based on necrosis lines. This research by John A. Russell et al. was published in JRRD in 2010.

derick
Download Presentation

Improved Tissue Survival with Nitric Oxide Donor Injection in Flap Surgery

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 1. Representative photograph of increased tissue survival noted following injection of nitric oxide donor DETA-NO. Arrows designate line of necrosis. (a) Control flap. (b) DETA-NO treated flap. DETA-NO = diethylenetriamine NONOate. John A. Russell, MS; et al. JRRD 2010; 47.1: 61-66

More Related